February 2016 Issue Table Of Contents

From The Editor

• Biopharma — Beware Of The Activist Investor

Feature Articles

• Novo Nordisk Turns Adversity Into Opportunity
• Inside A Hostile Takeover
• Companies To Watch Roundup

Capitol Perspectives

• ObamaCare On The Precipice

Companies To Watch

• Symic Biomedical

Inside The Industry

• Assessing The Discovery Outsourced Services Market
• Otsuka Alters Study Paradigms To Prepare Sites For Clinical Success
• How Efficient Is The Toyota Production System In Biopharma?

Industry Leader

• 3 Keys To Successful Industry-Academic Collaborations
• How Lab Improvements Can Drive Productivity

Leadership Lessons

• The Power Of Specificity

Ask The Board

• Will CRISPR Deliver On The Promise To Transform The Field Of Biology – Why Or Why Not?
• What Are Your Top Books On Leadership And Why?
• What Low-Cost Initiatives Could Help Improve Clinical Trials?